These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 31787850)

  • 1. Long noncoding RNA DLX6-AS1 promotes neuroblastoma progression by regulating miR-107/BDNF pathway.
    Zhang HY; Xing MQ; Guo J; Zhao JC; Chen X; Jiang Z; Zhang H; Dong Q
    Cancer Cell Int; 2019; 19():313. PubMed ID: 31787850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA DLX6-AS1 promoted cancer cell proliferation and invasion by attenuating the endogenous function of miR-181b in pancreatic cancer.
    An Y; Chen XM; Yang Y; Mo F; Jiang Y; Sun DL; Cai HH
    Cancer Cell Int; 2018; 18():143. PubMed ID: 30250401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockdown of lncRNA DLX6-AS1 inhibits cell proliferation, migration and invasion while promotes apoptosis by downregulating PRR11 expression and upregulating miR-144 in non-small cell lung cancer.
    Huang Y; Ni R; Wang J; Liu Y
    Biomed Pharmacother; 2019 Jan; 109():1851-1859. PubMed ID: 30551440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA DLX6-AS1 Promotes the Progression of Neuroblastoma by Activating STAT2 via Targeting miR-506-3p.
    Hu Y; Sun H; Hu J; Zhang X
    Cancer Manag Res; 2020; 12():7451-7463. PubMed ID: 32904436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silencing of long non-coding RNA DLX6-AS1 weakens neuroblastoma progression by the miR-513c-5p/PLK4 axis.
    Jia P; Wei E; Liu H; Wu T; Wang H
    IUBMB Life; 2020 Dec; 72(12):2627-2636. PubMed ID: 33031637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA DLX6-AS1 knockdown suppresses the tumorigenesis and progression of non-small cell lung cancer through microRNA-16-5p/BMI1 axis.
    Wu C; Lin W; Fu F
    Transl Cancer Res; 2021 Aug; 10(8):3772-3787. PubMed ID: 35116677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA DLX6-AS1 aggravates the development of ovarian cancer via modulating FHL2 by sponging miR-195-5p.
    Kong L; Zhang C
    Cancer Cell Int; 2020; 20():370. PubMed ID: 32774164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DLX6-AS1/miR-204-5p/OCT1 positive feedback loop promotes tumor progression and epithelial-mesenchymal transition in gastric cancer.
    Liang Y; Zhang CD; Zhang C; Dai DQ
    Gastric Cancer; 2020 Mar; 23(2):212-227. PubMed ID: 31463827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The up-regulated lncRNA DLX6-AS1 in colorectal cancer promotes cell proliferation, invasion and migration via modulating PI3K/AKT/mTOR pathway.
    Zhang JJ; Xu WR; Chen B; Wang YY; Yang N; Wang LJ; Zhang YL
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8321-8331. PubMed ID: 31646562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA DLX6-AS1 acts as an oncogene by targeting miR-613 in ovarian cancer.
    You Q; Shi HY; Gong CF; Tian XY; Li S
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6429-6435. PubMed ID: 31378881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA DLX6-AS1 promotes tumor proliferation and metastasis in osteosarcoma through modulating miR-641/HOXA9 signaling pathway.
    Zhang N; Meng X; Mei L; Zhao C; Chen W
    J Cell Biochem; 2019 Jul; 120(7):11478-11489. PubMed ID: 30838699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The lncRNA DLX6-AS1 promoted cell proliferation, invasion, migration and epithelial-to-mesenchymal transition in bladder cancer via modulating Wnt/β-catenin signaling pathway.
    Guo J; Chen Z; Jiang H; Yu Z; Peng J; Xie J; Li Z; Wu W; Cheng Z; Xiao K
    Cancer Cell Int; 2019; 19():312. PubMed ID: 31787849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long noncoding RNA DLX6-AS1 promotes tumorigenesis by modulating miR-497-5p/FZD4/FZD6/Wnt/β-catenin pathway in pancreatic cancer.
    Yang J; Ye Z; Mei D; Gu H; Zhang J
    Cancer Manag Res; 2019; 11():4209-4221. PubMed ID: 31118816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The regulatory network of lncRNA DLX6-AS1/miR-149-5p/ERP44 is possibly related to the progression of preeclampsia.
    Liu R; Wang X; Yan Q
    Placenta; 2020 Apr; 93():34-42. PubMed ID: 32250737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNA TP73-AS1 sponges miR-194 to promote colorectal cancer cell proliferation, migration and invasion via up-regulating TGFα.
    Cai Y; Yan P; Zhang G; Yang W; Wang H; Cheng X
    Cancer Biomark; 2018; 23(1):145-156. PubMed ID: 30010111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA DLX6-AS1/miR-141-3p axis regulates osteosarcoma proliferation, migration and invasion through regulating Rab10.
    Guo Q; Sun H; Zheng K; Yin S; Niu J
    RSC Adv; 2019 Oct; 9(58):33823-33833. PubMed ID: 35528911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long noncoding RNA DLX6-AS1 functions as a competing endogenous RNA for miR-577 to promote malignant development of colorectal cancer.
    Zhou FR; Pan ZP; Shen F; Huang LQ; Cui JH; Cai K; Guo XL
    Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3742-3748. PubMed ID: 31115000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA
    Sun W; Zhang L; Yan R; Yang Y; Meng X
    Onco Targets Ther; 2019; 12():3945-3954. PubMed ID: 31190891
    [No Abstract]   [Full Text] [Related]  

  • 19. LncRNA DLX6-AS1 increases the expression of HIF-1α and promotes the malignant phenotypes of nasopharyngeal carcinoma cells via targeting MiR-199a-5p.
    Yang B; Jia L; Ren H; Jin C; Ren Q; Zhang H; Hu D; Zhang H; Hu L; Xie T
    Mol Genet Genomic Med; 2020 Jan; 8(1):e1017. PubMed ID: 31782911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long Noncoding RNA
    Xie F; Xie G; Sun Q
    Cancer Biother Radiopharm; 2020 Mar; 35(2):129-136. PubMed ID: 32077747
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.